News & ViewsNewslettersContactBecome a Research Patient
DHRHealth Institute for Research and Development

Clinical Trial

The Texas Hepatocellular Carcinoma Consortium (THCCC); Risk Stratification For and Early Detection of Liver Cancer (U01)

Study Status:

Not Yet Recruiting

Please contact us for more information or to learn if you are eligible to participate.

Study Purpose:

The purpose of this study is the identification of risk factors and early detection of HCC with emphasis on the high-risk Cirrhotic patient population.

Information: 

Principal Investigator
Rashmee Patil, MD
Sponsor
Baylor College of Medicine
Type of Trial
Observational
© 2023 DHR Health Institute for Research & Development | All Rights Reserved | Terms & Conditions | Site By: KangoMedia
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram